Atlas Trials

Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)

Clinical trial NCT05107557 · COMPLETED

Trial details

NCT number
NCT05107557
Sponsor
Sinovac Biotech Co., Ltd
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19
Start date
2021-11-05
Primary completion
2021-12-05
Enrollment
520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.